NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

13 hedge funds and large institutions have $1.12M invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$155K
2
+$104K
3
+$8.66K
4
UBS Group
UBS Group
Switzerland
+$3.33K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
+$2K

Top Sellers

1
-$104K
2
-$26.5K
3
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$729K
2
$104K
3
$91K
4
$71K
5
$57K
6
$54K
7
$4K
8
$2K
9
$2K
10
$1K
11
$1K
12
–
13
–